Publication | Closed Access

Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties

Regenerative MedicineHeart FailureCardiogenic ShockCardiovascular DiseaseMedicineStem-cell TherapyBiomedical EngineeringMesenchymal Stem CellStem CellsCell TransplantationCardiologyVentricular FunctionAcute Myocardial InfarctionMyocardial Infarction